These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5597697)

  • 1. [On the question of activators of fibrinolysis in the amniotic fluid and in placental extracts of full-term pregnancies].
    Slunský R; Adamcová M
    Z Geburtshilfe Gynakol; 1967 Oct; 167(3):337-44. PubMed ID: 5597697
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the inhibitors of fibrinolysis in the amniotic fluid and in the placental extracts of full term pregnancies].
    Slunský R; Adamcová M
    Z Geburtshilfe Gynakol; 1967; 167(2):224-31. PubMed ID: 5590814
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the question of fibrinolysis inhibitors in the amniotic fluid and in extracts of chorionic villi and decidua in early pregnancies].
    Slunský R; Adamcová M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1968; 89(1):60-70. PubMed ID: 4174212
    [No Abstract]   [Full Text] [Related]  

  • 4. [On activators and inhibitors of fibrinolysis in the amniotic fluid and in extracts of the placenta, decidua and myometrium of interrupted and normally terminated pregnancies].
    Slunský R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):236-43. PubMed ID: 4174664
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of antifibrinolytics and heparin on the toxicity of placental, brain and amniotic fluid thromboplastins in rats.
    Koutský J; Hladovec J; Bednár B
    Acta Univ Carol Med (Praha); 1971; 17(7):477-86. PubMed ID: 5163359
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trasylol as inhibitor of the thromboplastic effect of amniotic fluid and placental extracts].
    Slunsky R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(3):338-45. PubMed ID: 4123098
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assessment of amniotic fluid fibrinolytic activity (author's transl)].
    Hernandez A; Parrilla JJ; Aznar J; Gilabert J; Estelles A
    Sangre (Barc); 1975; 20(2):108-12. PubMed ID: 124956
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible origin of amniotic fluid constituents influencing fibrinolytic activity.
    Pajor A; Gróf J; Menyhárt J
    Haematologia (Budap); 1984; 17(4):443-8. PubMed ID: 6532914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [THE THROMBOPLASTIC ACTIVITY OF THE AMNIOTIC FLUID AND OF THE PLACENTAL EXTRACT IN FULL-TERM PREGNANCIES].
    SLUNSKY R
    Z Geburtshilfe Gynakol; 1963 Sep; 161():56-65. PubMed ID: 14093618
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the problem of enzymes supporting fibrinolysis in the amniotic fluid and in the placental and decidual extracts from early pregnancy].
    Slunský R; Adamcová M
    Cesk Gynekol; 1967 Feb; 32(1):110-3. PubMed ID: 6044934
    [No Abstract]   [Full Text] [Related]  

  • 11. [Coagulation-active phospholipids. Contribution to the coagulation-physiological and chemical characterization of thrombocyte and placental extracts rich on phosphatides].
    Trobisch H; Schwinn H
    Med Welt; 1974 Oct; 25(40):1604-8. PubMed ID: 4444498
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of unprocessed placental extracts from term pregnancies on fibrinolysis (euglobulin test)].
    Slunský R; Adamcová M
    Zentralbl Gynakol; 1968 Jul; 90(29):995-9. PubMed ID: 5691243
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of oxytocin on the coagulating properties of the blood and on the thrombocyte formation activation processes by placental tissue activators during labor].
    Susloparov LA
    Vopr Okhr Materin Det; 1973; 18(4):72-7. PubMed ID: 4802777
    [No Abstract]   [Full Text] [Related]  

  • 14. [Levels of human placental lactogen in amniotic fluid in pregnancies with Rh isoimmunization].
    Karag'ozova Zh; Atanasov B; Zakharieva B
    Akush Ginekol (Sofiia); 1982; 21(5):392-6. PubMed ID: 6817651
    [No Abstract]   [Full Text] [Related]  

  • 15. Pregnancy-specific beta 1-glycoprotein in amniotic fluid in high risk late pregnancy.
    Heikinheimo M
    Oncodev Biol Med; 1980; 1(4-5):287-90. PubMed ID: 6974344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decidual, amniotic fluid, maternal and fetal prolactin in normal and abnormal pregnancies.
    Luciano AA; Varner MW
    Obstet Gynecol; 1984 Mar; 63(3):384-8. PubMed ID: 6366659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy specific beta 1-glycoprotein and human chorionic gonadotrophin levels n amniotic fluid and maternal serum in the first half of pregnancy.
    Heikinheimo M; Seppälä M; Brock DJ
    Oncodev Biol Med; 1980 Aug; 1(1):71-6. PubMed ID: 6974343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of plasminogen and other fibrinolytic parameters in the amniotic fluid.
    Aznar J; Gilabert J; Estelles A; Parrilla JJ
    Thromb Haemost; 1980 Jun; 43(2):182. PubMed ID: 7455978
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of the inhibitor of plasminogen activation in the euglobulin test.
    Januszko T; Buluk K; Uszyńska-Folejewska R; Uszyński M
    Pol Med J; 1966; 5(4):914-9. PubMed ID: 5964912
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
    Kanfer A; Bruch JF; Nguyen G; He CJ; Delarue F; Flahault A; Nessmann C; Uzan S
    Lab Invest; 1996 Jan; 74(1):253-8. PubMed ID: 8569189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.